Adamax

Compound Overview

Adamax, described in the source research data as Adamantyl-Tyrosine dipeptide, is a small nootropic research compound structurally related to BDNF-modulating peptides. The provided research summary identifies Adamax as a compound studied for potential interactions with neurotrophic signaling pathways, particularly Brain-Derived Neurotrophic Factor (BDNF) and TrkB receptor signaling.

The source classification places Adamax within the broader Semax/BDNF research family. That classification is useful for laboratory context because it frames Adamax as a peptide-related research material associated with neurotrophic signaling models rather than as a consumer supplement, therapeutic product, or clinical-use material. Nexus supplies Adamax only as a research reagent for qualified in-vitro workflows.

No CAS number, molecular formula, amino-acid sequence, or expanded structural diagram was provided in the supplied Adamax data. Those fields are intentionally omitted from this description rather than reconstructed from external references or assumed from adjacent compounds.

Research Background & Published Literature

The provided research background describes Adamax as investigated in cognitive and neuroprotective research models. It is presented as part of a broader family of small peptide nootropics studied for effects on neuroplasticity, memory consolidation, and neuroprotection signaling cascades in controlled research settings.

Research interest in Adamax is centered on neurotrophic signaling, including BDNF-associated pathways and TrkB receptor signaling. These terms are included here strictly as research descriptors from the source data. They are not presented as therapeutic claims, human-use claims, veterinary-use claims, or dosing guidance.

Researchers reviewing Adamax should interpret this literature within controlled laboratory boundaries. Nexus does not position Adamax for diagnosis, treatment, prevention, mitigation, human experimentation, veterinary application, or any bodily use.

Researchers reviewing the literature around this compound can use the peer-reviewed resources below for additional context on mechanism of action, signaling pathways, and controlled laboratory research applications:

• Vakhitova et al. (2021) — Int J Mol Sci
• Zainullina et al. (2021) — Sci Rep
• Povarnina et al. (2022) — Acta Naturae

Storage, Handling & Stability Guidelines

Use the applicable lot/source record for storage of unopened material. Any diluent selection, preparation, temperature, aliquoting, or post-reconstitution hold conditions must be established by a qualified laboratory under a validated SOP; this page does not establish a stability window.

• Store sealed lyophilized Adamax at -20°C for long-term inventory control.
• Use a validated laboratory SOP and the applicable lot/source record for any preparation or post-reconstitution handling.
• Limit repeated freeze-thaw exposure by aliquoting working volumes when compatible with the research protocol.
• Protect material from unnecessary moisture exposure during handling.
• Use appropriate PPE, labeling, and institutional chemical-safety controls for research reagents.
• Label aliquots with compound name, concentration, reconstitution date, and operator initials for traceability.

The source data does not provide a validated reconstitution solvent, post-reconstitution expiration interval, or stability study. Those values should be established only through laboratory-validated protocols or lot-specific documentation, not assumed from this description.

Quality Assurance & Lab Verification

The Certificate of Analysis for this catalog item is pending. No provisional batch, assay, method, analyst, or release data is published in this product dossier. Check the Lab Verified archive for documentation status.